Cytokinetics (CYTK) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.11 -1.65%
Revenue Growth %: +1,960.6%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +1,960.6%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $11.24 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Cooper Companies tumbles on weak guidance, strategic review conclusion
- Hagerty prices upsized secondary offering at $11.95 per share
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
